Towards Healthcare
U.S. Compounding Pharmacy Market to Lead USD 12.02 Bn by 2034

U.S. Compounding Pharmacy Market Expands with AI Impact

According to forecasts, the U.S. compounding pharmacy market will grow from USD 6.57 billion in 2024 to USD 12.02 billion by 2034, with an expected CAGR of 6.24%. The rising incidence of chronic conditions like diabetes, arthritis, and cancer necessitates ongoing treatment regimens. Compounded medications offer flexibility in dosing and formulation, accommodating the complex needs of these patients.

Content

  • Last Updated: 23 September 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The U.S. compounding pharmacy market currently in 2025 records USD 6.98 billion and is anticipated to grow to USD 12.02 billion by 2034, advancing at a CAGR of 6.24% from 2024 to 2034.

The South U.S. is leading the U.S. compounding pharmacy market share by 30% due to the increasing demand for personalized medicines, rising investment & funding, and the presence of major key players.

Key trends include the growing need for biologics, advancements in manufacturing technology, and increasing collaborations.

Alliance for Pharmacy Compounding, Personalized Medicine Coalition, PCAB Accreditation for Compounding Pharmacies ACHC, American College of Apothecaries ACA, Food and Drug Administration, clinicaltrials.gov
Any Questions